Longitudinal measures of proteostasis in live neurons: features that determine fate in models of neurodegenerative disease
- PMID: 23458259
- DOI: 10.1016/j.febslet.2013.02.043
Longitudinal measures of proteostasis in live neurons: features that determine fate in models of neurodegenerative disease
Abstract
Protein misfolding and proteostasis decline is a common feature of many neurodegenerative diseases. However, modeling the complexity of proteostasis and the global cellular consequences of its disruption is a challenge, particularly in live neurons. Although conventional approaches, based on population measures and single "snapshots", can identify cellular changes during neurodegeneration, they fail to determine if these cellular events drive cell death or act as adaptive responses. Alternatively, a "systems" cell biology approach known as longitudinal survival analysis enables single neurons to be followed over the course of neurodegeneration. By capturing the dynamics of misfolded proteins and the multiple cellular events that occur along the way, the relationship of these events to each other and their importance and role during cell death can be determined. Quantitative models of proteostasis dysfunction may yield unique insight and novel therapeutic strategies for neurodegenerative disease.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration.Neuron. 2011 Jul 14;71(1):35-48. doi: 10.1016/j.neuron.2011.06.031. Neuron. 2011. PMID: 21745636 Review.
-
[Proteinopathies--forms of neurodegenerative disorders with protein aggregation-based pathology].Mol Biol (Mosk). 2012 May-Jun;46(3):402-15. Mol Biol (Mosk). 2012. PMID: 22888630 Review. Russian.
-
Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.Biofactors. 2017 Nov;43(6):737-759. doi: 10.1002/biof.1264. Epub 2016 Feb 22. Biofactors. 2017. PMID: 26899445 Review.
-
Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins.Cell Biochem Biophys. 2011 Nov;61(2):237-50. doi: 10.1007/s12013-011-9200-x. Cell Biochem Biophys. 2011. PMID: 21573992 Review.
-
[Amyloid aggregates: role in Protein Misfolding Disorders].Rev Med Chil. 2013 Apr;141(4):495-505. doi: 10.4067/S0034-98872013000400011. Rev Med Chil. 2013. PMID: 23900371 Review. Spanish.
Cited by
-
Proceedings: cell therapies for Parkinson's disease from discovery to clinic.Stem Cells Transl Med. 2014 Sep;3(9):979-91. doi: 10.5966/sctm.2014-0146. Epub 2014 Aug 22. Stem Cells Transl Med. 2014. PMID: 25150264 Free PMC article.
-
Hsp22 with an N-Terminal Domain Truncation Mediates a Reduction in Tau Protein Levels.Int J Mol Sci. 2020 Jul 30;21(15):5442. doi: 10.3390/ijms21155442. Int J Mol Sci. 2020. PMID: 32751642 Free PMC article.
-
Amelioration of toxicity in neuronal models of amyotrophic lateral sclerosis by hUPF1.Proc Natl Acad Sci U S A. 2015 Jun 23;112(25):7821-6. doi: 10.1073/pnas.1509744112. Epub 2015 Jun 8. Proc Natl Acad Sci U S A. 2015. PMID: 26056265 Free PMC article.
-
Automated microfluidic cell culture of stem cell derived dopaminergic neurons.Sci Rep. 2019 Feb 11;9(1):1796. doi: 10.1038/s41598-018-34828-3. Sci Rep. 2019. PMID: 30741972 Free PMC article.
-
Huntington's disease iPSC models-using human patient cells to understand the pathology caused by expanded CAG repeats.Fac Rev. 2022 Jun 28;11:16. doi: 10.12703/r/11-16. eCollection 2022. Fac Rev. 2022. PMID: 35865413 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources